Fluorometric CCHFV OTU protease assay with potent inhibitors
Crimean-Congo hemorrhagic fever virus (CCHFV) is a deadly virus that has been listed in the Category C as a potential bioterror agent. There are no specific therapies against CCHFV, which urges identification of potential therapeutic targets and development of CCHFV therapies. CCHFV OTU protease takes an important role in viral invasion through antagonizing NF-κB signaling. Inhibition of CCHFV OTU protease by small molecules warrants an exciting potential as antiviral therapeutics. Here we report the expression and purification of a C-His-tagged recombinant CCHFV OTU protease in E. coli BL21 (DE3) host strain. Activity of the refolded purified recombinant viral OTU protease has been validated with a UB-AMC fluorescent assay. In addition, we show a dose-dependent inhibition of the viral OTU protease by two small molecules. This study provides a reliable approach for recombinant expression and purification of CCHFV OTU protease, and demonstrates validation of OTU protease activity and its inhibition based on a UB-AMC florescent assay.
KeywordsViral OTU protease Expression and purification Fluorescent assay Antivirals Crimean-Congo hemorrhagic fever virus CCHFV CCHF
We thank Dr. Savas Kaya from Immunology Department, School of Medicine, Dicle University, Diyarbakir Turkey for his valuable input regarding MGLTools, and Autodock Vina. We thank Dr. Andrew J. Harvey from the Department of Genetics and Bioengineering, Faculty of Engineering, Yeditepe University, Istanbul, Turkey for his critical reading of the manuscript. We thank the support from Co-Funded Brain Circulation Scheme by The Scientific and Technological Research Council of Turkey (TÜBİTAK) and The Marie Curie Action COFUND of the 7th. Framework Programme (FP7) of the European Commission Grant#115C039, The Science Academy Young Scientist Award Program (BAGEP-2015, Turkey), funds provided by North American University, Houston, USA and Yeditepe University, Istanbul, Turkey.
Compliance with Ethical Standards
Conflict of interest
All authors declare that they have no conflicts of interest concerning this work.
- 1.N. Frias-Staheli, N.V. Giannakopoulos, M. Kikkert, S.L. Taylor, A. Bridgen, J. Paragas, J.A. Richt, R.R. Rowland, C.S. Schmaljohn, D.J. Lenschow, E.J. Snijder, A. García-Sastre, H.W. Virgin, Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses. Cell Host Microbe 2(6), 404–416 (2007)PubMedCentralCrossRefPubMedGoogle Scholar
- 5.G.C. Capodagli, M.A. McKercher, E.A. Baker, E.M. Masters, J.S. Brunzelle, S.D. Pegan, Structural analysis of a viral ovarian tumor domain protease from the crimean-congo hemorrhagic fever virus in complex with covalently bonded ubiquitin. J. Virol. 85, 3621–3630 (2011)PubMedCentralCrossRefPubMedGoogle Scholar
- 12.A. Gargili, K. Midilli, O. Ergonul, S. Ergin, H.G. Alp, Z. Vatansever, S. Iyisan, C. Cerit, G. Yilmaz, K. Altas, A. Estrada-Peña, Crimean-Congo hemorrhagic fever in European part of Turkey: genetic analysis of the virus strains from ticks and a seroepidemiological study in humans. Vector Borne Zoonotic Dis. 11, 747–752 (2011)CrossRefPubMedGoogle Scholar
- 15.M. Lindeborg, C. Barboutis, C. Ehrenborg, T. Fransson, T.G.T. Jaenson, P.-E. Lindgren, A. Lundkvist, F. Nyström, E. Salaneck, J. Waldenström, B. Olsen, Migratory birds, ticks, and Crimean-Congo hemorrhagic fever virus. Emerg. Infect. Dis. 18, 2095–2097 (2012)PubMedCentralCrossRefPubMedGoogle Scholar
- 17.P. Gale, B. Stephenson, A. Brouwer, M. Martinez, A. la de Torre, J. Bosch, M. Foley-Fisher, P. Bonilauri, A. Lindström, R.G. Ulrich, J. de Vos, M. Scremin, L. Kelly, Z. Liu, M.J. Muñoz, Impact of climate change on risk of incursion of Crimean-Congo haemorrhagic fever virus in livestock in Europe through migratory birds. J. Appl. Microbiol. 112, 246–257 (2012)CrossRefPubMedGoogle Scholar
- 21.T.W. James, N. Frias-Staheli, J.-P. Bacik, J.M. Levingston Macleod, M. Khajehpour, A. García-Sastre, B.L. Mark, Structural basis for the removal of ubiquitin and interferon-stimulated gene 15 by a viral ovarian tumor domain-containing protease. Proc. Natl. Acad. Sci. 108, 2222–2227 (2011)PubMedCentralCrossRefPubMedGoogle Scholar
- 26.O. Trott, A.J. Olson, AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31(2), 455–461 (2009)Google Scholar
- 29.T. Matsunaga, Y. Morikawa, M. Haga, S. Endo, M. Soda, K. Yamamura, O. El-Kabbani, K. Tajima, A. Ikari, A. Hara, Exposure to 9,10-phenanthrenequinone accelerates malignant progression of lung cancer cells through up-regulation of aldo-keto reductase 1B10. Toxicol. Appl. Pharmacol. 278, 180–189 (2014)CrossRefPubMedGoogle Scholar